Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 Agonist, Promotes Potent Systemic and Mucosal Responses to Intranasal Immunization with HIVgp140
Successful vaccine development against HIV will likely require the induction of strong, long-lasting humoral and cellular immune responses in both the systemic and mucosal compartments. Based on the known immunological linkage between the upper-respiratory and urogenital tracts, we explored the pote...
Main Authors: | Arias, Mauricio A., Van Roey, Griet A., Tregoning, John S., Moutaftsi, Magdalini, Coler, Rhea N., Windish, Hillarie P., Reed, Steven G., Carter, Darrick, Shattock, Robin J. |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400629/ |
Similar Items
-
Thymic stromal lymphopoietin (TSLP) acts as a potent mucosal adjuvant for HIV-1 gp140 vaccination in mice
by: Van Roey, Griet A, et al.
Published: (2012) -
The TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for TH1 Induction
by: Cauwelaert, Natasha Dubois, et al.
Published: (2016) -
Carnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigen
by: Arias, Mauricio A., et al.
Published: (2011) -
Computer-Aided Approaches for Targeting HIVgp41
by: Allen, William J., et al.
Published: (2012) -
Evaluation of TLR Agonists as Potential Mucosal Adjuvants for HIV gp140 and Tetanus Toxoid in Mice
by: Buffa, Viviana, et al.
Published: (2012)